研究领域
My research interest involved synthesis and evaluation of heterocyclic compounds, mainly coumarins; including their applications in rational drug design in the area of anticancer and Anti-HIV research. Coumarins, naturally occurring benzofurans, exhibit useful and diverse biological activities. In recent years, there has been a growing interest in their synthesis and possible applications as therapeutic agents for the treatment of various diseases such as breast cancer. Currently, my research goal focused on the following:
I. Design and Synthesis of Coumarin derivatives with anticancer and anti-HIV properties utilizing
innovative chemical synthetic techniques. Of particular interest are the Coumarin-based
selective estrogen receptor modulators (SERMs), coumarin-estrogen conjugates and coumarin
analogies of HIV-1 protease inhibitor, ritonavir.
II. Antiproliferative Studies using A549 and ER enriched MCF-7 breast cancer cells lines.
III. Molecular Modeling studies (Docking studies) of the coumarin ligands in the determination of
the relative binding affinity based upon binding energies and the conformational changes
imposed on the receptor.
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1. Musa, Musiliyu A.; Cooperwood, John S.; Khan, M. Omar F. Synthesis and antiproliferative
activity of coumarin-estrogen conjugates against breast cancer cell lines (Accepted for
publication, Letters in Drug Design & Discovery, Correspondence Reference number:
LDDD-6-2-13, 2009)
2. Musa, Musiliyu A.; Khan, M. Omar F.; Cooperwood, John S. Synthesis and biological evaluation
of coumarin-estrogen conjugates as antiproliferative agents. Abstracts of Papers, 236th ACS
National Meeting, Philadelphia, PA, United States, August 17-21, 2008 (2008).
3. Musa, Musiliyu A.; Cooperwood, John S.; Khan, M. Omar F. A review of coumarin derivatives in
pharmacotherapy of breast cancer, Current Medicinal Chemistry, 2008, 15(14), 2664-2679.
4. Musa Musiliyu A.; Khan M Omar F; Cooperwood John S. Medicinal Chemistry and Emerging
Strategies Applied to the Development of Selective Estrogen Receptor Modulations (SERMs),
Current Medicinal Chemistry, 2007; 14(11): 1249-61.
5. Kaye, Perry T.; Musa, Musiliyu A.; Nchinda, Aloysius T.; Nocanda, Xolani W. Novel Heterocyclic
Analogues of the HIV-1 Protease Inhibitor, Ritonavir, Synth. Commun, 2004, 34(14), 2575-2589.
6. Kaye, Perry T.; Musa, Musiliyu A. Regioselectivity of reaction of Nitrogen and Carbon
Nucleophile with coumarin derivatives, Synth. Commun. 2004, 34(18), 3409-3417.